5-Amino-1MQ inhibits NNMT, affecting multiple metabolic pathways: NAD+ Metabolism Nicotinamide preservation - Less substrate consumed by NNMT NAD+ precursor availability - More nicotinamide for salvage pathway Cellular energy - Potential effects on mitochondrial function Sirtuin activity - NAD+-dependent deacetylase regulation Methylation Balance SAM conservation - Reduced consumption by NNMT Methylation capacity - Effects on other methyltransferases Epigenetic regulation - Downstream effects on gene expression Adipose Tissue NNMT is highly expressed in fat - Key research target Adipocyte metabolism - Effects on lipid handling Obesity research - Understanding NNMTs role Metabolic Research NAD+ biology - Understanding salvage pathway regulation Energy metabolism - Mitochondrial function studies Adipose function - Fat tissue metabolism Longevity Research NAD+ and ageing - Cellular senescence studies Metabolic health - Age-related decline research Intervention targets - Therapeutic development Obesity Studies Adipose NNMT - Fat tissue expression studies Metabolic dysfunction - Disease mechanism research Specifications Storage Store at room temperature, protected from light and moisture
Protection against Neurodegeneration: Neurodegenerative diseases, such as Alzheimers and Parkinsons, can profoundly impact cognitive function
Single-use is strict but necessary in medical care
It tackles severe deficiency symptoms
Bulk Drug Substances That May Be Used in Compounding Under Section 503A of the Federal Food, Drug, and Cosmetic Act
At the forefront of this transformation is a powerful new combination therapy known as the Weight Loss Blend , featuring three synergistic peptides: SLU-PP-332 a PPAR agonist for metabolic enhancement 5-Amino-1MQ a fat loss catalyst targeting methylation and energy balance BPC-157 a regenerative peptide known for gut, vascular, and tissue healing Together, they offer a multidimensional strategy for sustainable fat loss, improved energy, reduced inflammation, and accelerated tissue repair
